It has been shown that CD36 is involved in lipid metabolism and homoeostasis and has been linked to pathological conditions associated with metabolic disorders, such as obesity, insulin resistance, diabetes, dyslipidemia and atherosclerosis [9, 14–17]. This evidence concerns the gene CD36 and metabolic disease.